A placebo-controlled, randomised clinical trial conducted by Shim B et al at Ewha Woman’s University in Seoul, South Korea, and supported by Frutarom Health BU, Switzerland, was published in April 2014.
Go-Less, developed and marketed by Frutarom Health BU, is a proprietary blend of a water-soluble pumpkin seed extract (EFLA940) and the soy germ extract, SoyLife. Separately, both ingredients have been successfully marketed for many years. Now, combined into the proprietary blend Go-Less, they show a combined effect of the constituents from pumpkin seeds and the hormone-balancing action of soy germ isoflavones.
The study included 120 women suffering from overactive-bladder-related voiding dysfunction. The women, aged between 35 and 70 years, took 500mg of Go-Less or matching placebo tablets (60 placebo/60 test group) twice a day during a 12-week period. The average frequency of nocturia was measured, showing a notable decrease of around 30%.
After week 12, a significant decrease of the daily average frequency of urination was reported. More critically, there was a substantial decrease in the average urgency score in the Go-Less group.
The functionality of Go-Less was also confirmed by a survey on the subjective satisfaction of the participants, as conducted at the end of the trial period. More than 90% of the subjects in the Go-Less group found the product helpful and answered affirmatively when asked if they would like to continue taking the study product. This compares to about 50% in the placebo group.
© FoodBev Media Ltd 2022
World Beverage Innovation Awards – NOW OPEN FOR ENTRIES!
The awards celebrate excellence and innovation across the global beverage industry.
Don’t miss out on having your innovations recognised on a global scale.
Deadline for entries 23 July – enter now!
Don’t get left behind
Start your free Foodbev magazine trial today and join thousands of fellow industry professionals in receiving food and drink trends direct to our business.
Click here to start your free trial